ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,469Medicare Part D Prescriptions Filled, Including Refills

Rank: 368 out of 6645

$559K Total Retail Price of All Prescriptions

Rank: 971 out of 6645

563 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 12,227 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 883 783 1 3
SIMVASTATIN 746 658 2 1
LEVOTHYROXINE SODIUM 650 577 3 4
OMEPRAZOLE 485 401 4 6
HYDROCODONE-ACETAMINOPHEN 477 263 S3 5 5
AMLODIPINE BESYLATE 468 420 6 2
HYDROCHLOROTHIAZIDE 438 391 7 9
METOPROLOL TARTRATE 351 342 8 13
FUROSEMIDE 324 279 9 11
ATORVASTATIN CALCIUM 308 281 10 10
METOPROLOL SUCCINATE 307 272 11 24
LOSARTAN POTASSIUM 272 263 12 12
WARFARIN SODIUM 270 269 13 16
POTASSIUM CHLORIDE 245 215 14 28
PRAVASTATIN SODIUM 238 229 15 20
METFORMIN HCL 217 188 16 7
LOVASTATIN 195 182 17 15
ATENOLOL 188 169 18 8
SERTRALINE HCL 168 114 19 43
GABAPENTIN 163 108 20 18
METFORMIN HCL ER 144 120 21 89
FLUTICASONE PROPIONATE 143 118 22 26
ALENDRONATE SODIUM 128 128 23 14
RANITIDINE HCL 126 122 24 51
ADVAIR DISKUS 125 115 25 45
DIOVAN 114 101 26 19
TAMSULOSIN HCL 105 98 27 22
PANTOPRAZOLE SODIUM 104 90 28 29
FLUOXETINE HCL 102 67 29 63
ZOLPIDEM TARTRATE 101 74 30 17
PROAIR HFA 101 90 30 32
GLIPIZIDE ER 97 80 32 239
JANUVIA 97 68 32 38
KLOR-CON 10 93 77 34 145
PAROXETINE HCL 90 64 35 72
ALLOPURINOL 88 55 36 31
CLOPIDOGREL 88 83 36 36
CITALOPRAM HBR 87 82 38 35
DOXAZOSIN MESYLATE 87 84 38 81
SPIRONOLACTONE 83 66 40 85
GLIPIZIDE 83 63 40 23
MIRTAZAPINE 82 45 42 70
DONEPEZIL HCL 79 79 43 27
TRAZODONE HCL 78 58 44 60
CARVEDILOL 73 46 45 25
ISOSORBIDE MONONITRATE ER 71 71 46 66
GLIPIZIDE XL 70 65 47 315
PLAVIX 69 64 48 49
BENAZEPRIL HCL 68 57 49 21
CARISOPRODOL 67 31 R 50 94
PREDNISONE 66 59 51 57
SPIRIVA 63 56 52 65
DILTIAZEM 24HR ER 62 62 53 187
DILTIAZEM ER 59 56 54 182
KLOR-CON 8 58 45 55 123
MELOXICAM 58 58 55 46
LANTUS 57 39 57 50
INSULIN SYRINGE 56 40 58 61
ESTRADIOL 55 53 R 59 165
FINASTERIDE 55 55 59 73
DILTIAZEM 24HR CD 54 54 61 176
FENOFIBRATE 54 18 61 74
MORPHINE SULFATE ER 53 22 S2 63 124
LEVOXYL 53 52 63 136
VENLAFAXINE HCL ER 53 23 63 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.